FDA Approves Prescription Nasal Spray to Reverse Opioid Overdose Nalmefene Hydrochloride Product in Nasal Spray Form Provides Additional Tool for Harm Reduction Groups and First Responders

https://www.fda.gov/news-events/press-announcements/fda-approves-prescription-nasal-spray-reverse-opioid-overdose?utm_medium=email&utm_source=govdelivery